Susan Sandler

The regulatory keynote and the Global Regulatory Town Hall panel discussion at the 2022 ISPE Annual Meeting & Expo on 2 November provided insights into regulations and the changing scene with increased...

The gavel passed to a new International Board Chair and ISPE leaders shared 2022 achievements and plans for 2023 at the 2022 ISPE Membership Meeting and Awards Lunch.

The industry is in the process of a transformation that was sped up by the pandemic, which enhanced innovation and collaboration. Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. The keynote presentations on 1...

The 2022 ISPE Annual Meeting & Expo opened with three keynote addresses exploring quality from a key FDA leader’s point of view, a major pharmaceutical company’s ongoing journey of transformation into an organization that is prepared to adapt to the changing world, and a unique patient perspective with a patient presenter who is also a member of the pharmaceutical community.

More than 400 attendees learned about the latest developments in biopharmaceuticals, cell and gene therapy, and ATMPs at the 2022 ISPE Biotechnology Conference, held 28–30 June in Boston, Massachusetts.

ISPE has more than 19,000 members from more than 129 countries, and many of them spend countless hours sharing their knowledge and connecting with others, helping ISPE to advance the educational and technical efficiency of all members.